Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

27.59
-0.4180-1.49%
Volume:6.92M
Turnover:191.68M
Market Cap:156.84B
PE:36.30
High:28.00
Open:27.90
Low:27.54
Close:28.00
52wk High:29.21
52wk Low:23.62
Shares:5.69B
Float Shares:5.64B
Volume Ratio:0.80
T/O Rate:0.12%
Dividend:1.72
Dividend Rate:6.23%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.84
PE(LYR):20.22

Loading ...

Medicus Pharma Shares Down 20.5% Premarket; Co, Pfizer Enter Licensing Deal for Experimental Cancer Therapy

THOMSON REUTERS
·
Sep 03

Medicus Pharma Surges on Pfizer Licensing Deal for Experimental Cancer Therapy

Reuters
·
Sep 03

Medicus Pharma Signs Co-Development, Licensing Deal with Pfizer for Cd228v Antibody-Drug Conjugate

Reuters
·
Sep 03

Medicus Pharma - Pays Pfizer $12 Mln Upfront, $15 Mln Due on First Anniversary - SEC Filing

THOMSON REUTERS
·
Sep 03

Medicus Pharma - Pfizer Paid the Company a One-Time, Non-Refundable Payment of $2.0 Million

THOMSON REUTERS
·
Sep 03

Medicus Pharma - Enters Co-Development and License Agreement with Pfizer on Sept 2, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 03

NYSE Most Active Issues

Dow Jones
·
Sep 03

Pfizer Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 03

Pfizer’s New Asthma Candidate PF-08103402 Enters Phase 1: What Investors Should Know

TIPRANKS
·
Sep 03

Top AI Healthcare Stocks For September 2026

Simply Wall St.
·
Sep 02

Pfizer (PFE) Following FDA Vaccine Approval Has Fair Value Back In Focus

Simply Wall St.
·
Sep 02

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

Did Targeted XFG COVID Shots Just Recenter Pfizer's (PFE) Post‑Pandemic Investment Narrative?

Simply Wall St.
·
Sep 01

NYSE Most Active Issues

Dow Jones
·
Sep 01

Pfizer Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 01

Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others

Reuters
·
Sep 01

Pfizer Pivots: New Trials Target Obesity, Cancer, Autoimmune

TIPRANKS
·
Aug 29

Pfizer EVP Cecile Guegan Files Initial Beneficial Ownership Statement

Reuters
·
Aug 29

Pfizer Extends Tucatinib Access With New Continuation Study: What Investors Should Know

TIPRANKS
·
Aug 29

Pfizer Expands Autoimmune Pipeline With New Early-Stage Trial of PF-08154225

TIPRANKS
·
Aug 29